Stock Market Reviews

LSH (Lakeside Holding Limited) News

Get the latest news, insights, and market updates on LSH (Lakeside Holding Limited). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Lakeside Partners with Huiyu Pharmaceutical to Revolutionize Oncology Drug Distribution
  Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market today announced that Hupan Pharmaceutical has entered into a strategic distribution agreement with Sichuan Huiyu Pharmaceutical Co., Ltd. ("Huiyu Pharmaceutical").
  Jan 7, 2025 - $LSH
• Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary
  Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market is pleased to announce that Hupan Pharmaceutical has signed a Sales Agreement (the "Agreement") with Sinopharm Holding Hubei New Special Medicine Co., Ltd. ("Sinopharm Hubei"), a subsidiary of Sinopharm Group. The Agreement, valued at approximately RMB 11.0 million (approximately $1.5 million), is effective from January 1, 2
  Dec 17, 2024 - $LSH
• Lakeside Holding to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
  Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market operating under the brand American Bear Logistics ("ABL"), today announced it will be presenting at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024 at the New York Athletic Club in New York City.
  Dec 3, 2024 - $LSH
• Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts
  Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market operating under the brand American Bear Logistics ("ABL"), announces that Hupan Pharmaceutical (Hubei) Co., Ltd. ("Hupan Pharmaceutical"), a company recently acquired by Lakeside, has established partnership with Sinopharm Group Hubei Co., Ltd. ("Sinopharm Hubei"). Sinopharm Hubei is a subsidiary of Sinopharm Group Co
  Nov 25, 2024 - $LSH